Introduction to Kocitaf Tablet
Kocitaf Tablet combines anti retroviral medications to treat HIV-1 infection in adults and adolescents aged 12 and older, weighing at least 35kg. Dolutegravir, an integrase strand transfer inhibitor (INSTI), works with Emtricitabine, a nucleoside reverse transcriptase inhibitor (NRTI), and Tenofovir alafenamide, a nucleotide reverse transcriptase inhibitor (NtRTI). This single tablet regimen simplifies HIV treatment, improving adherence by reducing daily pill intake. Regular HIV testing is essential while using this medicine.
Uses
- HIV infection
Therapeutic Effects
Kocitaf Tablet effectively reduces HIV viral load, maintains long-term suppression, and slows disease progression. Its single tablet regimen enhances adherence and offers a safer profile with reduced risks of renal and bone toxicity. This treatment helps patients maintain better health outcomes while simplifying their medication routine.
Interaction of Kocitaf Tablet with Other Drugs
Inform your healthcare provider about all medications you are taking, including prescriptions, over the counter drugs, vitamins, and supplements. Some medicines interact with it, reducing its effectiveness or causing side effects. Always consult your doctor before starting or stopping any medication while on this treatment.
More Information about Kocitaf Tablet
- Store below 30°C
- Protect from light and moisture
- Keep away from children and pets
- If you miss a dose, take the next dose at the scheduled time without doubling it.
How to Consume Kocitaf Tablet
Take it as prescribed, with or without food. Swallow it whole with water, without crushing or chewing. If you have trouble swallowing, consult your doctor before splitting the tablet. Stick to your prescribed schedule to ensure effective treatment and better health management.
Reviews
There are no reviews yet.